Clinical Trials Logo

Otorhinolaryngologic Diseases clinical trials

View clinical trials related to Otorhinolaryngologic Diseases.

Filter by:

NCT ID: NCT03931226 Completed - Respiratory Disease Clinical Trials

Impact of Spa Treatments on the Consumption of Care in Children

PEDIATHERM
Start date: June 1, 2018
Phase:
Study type: Observational

Children represent 1.2% of the spa population in France. Spa treatments, including climatic stays, are mainly prescribed for children in the context of respiratory, otorhinolaryngology and dermatological conditions. The benefits after spa treatments are the improvement of the symptoms of the pathology, the quality of life and in particular the reduction of drug exposures. Few authors have recently investigated the impact of spa treatments on the health of children and society, while care has changed significantly in recent years. Moreover, no real-life study of a large sample of children seems to have been conducted in this area. The present study plan to conduct a pharmacoepidemiology study on medico-administrative databases of the "observational study" type, in real life.

NCT ID: NCT03793816 Completed - Postoperative Pain Clinical Trials

Tonsillectomy Using BiZactâ„¢ - a Randomized Side-controlled Clinical Trial

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

Tonsillectomies are frequently followed by severe postoperative pain, hence high analgetics consumption and prolonged hospitalization. Also, postoperative hemorrhages can be hazardous. Constant evaluation of surgical techniques is paramount to improve safety and cost-effectiveness. Frequently tonsillectomies are performed in cold steel technique. Aim of this study will be the evaluation of handling, surgical time, postoperative pain and postoperative hemorrhage rates using the BiZactTM-Device in comparison to traditional techniques on the contralateral side. In one patient, two different techniques will be used. The primary objective will be the surgical time. Regardless of surgeon handedness, surgeons will randomly be assigned to either start with the left or right tonsil, and randomly either to start with the BiZactâ„¢ Device or with "cold steel" methods. Additionally, time to stop bleeding, intraoperative blood loss, tonsil mobility, device handling, as well as wound healing will be assessed.

NCT ID: NCT03783702 Completed - Pain Clinical Trials

Pain Control Following Sinus Surgery

Start date: April 4, 2019
Phase: Phase 4
Study type: Interventional

Given the ongoing national opioid epidemic, an increased interest has developed in optimizing opioid prescribing practices of physicians, including otolaryngologists. Endoscopic sinus surgery (ESS) is one of the most commonly performed surgeries by otolaryngologists with over 250,000 ESS's performed annually in the U.S. Multiple studies have shown that, compared to the amount patients actually consume, otolaryngologists prescribe a high quantity of opioids to patients recovering from ESS). It has been shown that these excess opioid medications contribute to prolonged use or abuse by the patient, family members, or friends. The purpose of this study is to better understand the pain management requirements of patients who undergo ESS for recurrent acute rhinosinusitis (RARS) or chronic rhinosinusitis (CRS). This prospective, randomized, multi-institutional controlled trial will aim to determine the degree to which pain following ESS can be adequately controlled by non-opioid medications. It will also determine whether post-ESS narcotic use can be avoided entirely, or at least significantly limited. Patients will be randomized into two groups, each of which will receive a stepwise analgesic regimen consisting of acetaminophen and oxycodone or acetaminophen and ibuprofen. Pain will be assessed daily using visual analog scales (VAS) and the Brief Pain Inventory (BPI). The results of this study will help to develop a standardized approach to pain management in the post-ESS setting and help to elucidate the role of non-opioid pain medications. The ultimate goal would be to positively affect opioid prescribing patterns among surgeons who perform ESS in order to significantly reduce the quantity of opioids prescribed to patients while continuing to adequately manage patients' pain.

NCT ID: NCT03695666 Completed - ENT Disease Clinical Trials

A Completed-cycle Local Audit of Patient Load in the SHO-led ENT Casualty Clinic

Start date: November 1, 2017
Phase:
Study type: Observational

ENT UK guidelines recommend booking no more than 6 patients during each 4-hour clinic session. Retrospectively, the investigators counted patients booked for each clinic on ourbooking system. The second cycle showed improved compliance with guidelines.

NCT ID: NCT03243344 Completed - Clinical trials for Otorhinolaryngologic Diseases

Randomized Assessment of Devices Used to Prevent Post-operative Hemorrhagic Risk in Endonasal Surgery

PRHEPOCE
Start date: March 2010
Phase: N/A
Study type: Interventional

This study evaluates the efficiency and the cost of three medical devices and the abstention of the use of specific product for the post-operative haemostasis in endonasal surgery .

NCT ID: NCT03167463 Recruiting - Clinical trials for Otolaryngological Disease

Stentless Endoscopic Transnasal Transseptal Choanoplasty

Start date: May 19, 2017
Phase: N/A
Study type: Interventional

Congenital choanal atresia is an abnormality of the posterior nasal passages resulting in complete or partial obstruction of the nasal airways. It has an incidence of 1: 5000 to 8000 live births, with a female predominance. 41% - 72% occur in conjunction with non-syndromic facial abnormalities such as arched palate, cleft lip, and auricular deformities. About 4% present as a component of chromosomally-based syndromes such as (coloboma, heart defect, atresia choanae, retarded growth, genital abnormality, and ear abnormality" and Treacher Collins syndromes. Previous reports have described the ratio of bony to membranous choanal atresia as 9:1. However, a detailed review of computed tomography study combined with histopathological studies has shown mixed bony-membranous atresia in about 70% of cases and purely bony atresia in 30% of cases.

NCT ID: NCT03010813 Completed - Clinical trials for Colorectal Neoplasms

A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery

Start date: December 2016
Phase: N/A
Study type: Interventional

This is a prospective, single center, multispecialty study that aimed to evaluate the clinical feasibility and safety of single port surgery and NOTES (mainly transanal and transoral surgery) using a novel single port robotic system.

NCT ID: NCT02965183 Not yet recruiting - Clinical trials for Otolaryngological Diseases

The Correlation Between Adenoid Hypertrophy and Body Temperature in Children Before and After Adenoidectomy

Start date: December 2016
Phase: N/A
Study type: Interventional

Examination of the correlation between adenoid hypertrophy and body temperature in candidate children for adenoidectomy after exercise

NCT ID: NCT02927652 Completed - Clinical trials for Otorhinolaryngologic Diseases

Psychiatric Comorbidity

Start date: January 23, 2017
Phase:
Study type: Observational

The goals of this project are aimed at the following: 1. Identifying psychiatric comorbidity in patients presenting to the HNSCS clinic 1F and Duke Otolaryngology of Raleigh clinic using the validated assessment tool Brief Symptom Inventory (BSI-18) and the patient control scale. The BSI-18 is an 18 question and patient control an 8 item tool that takes about four minutes to complete. 2. Gathering data regarding patient satisfaction in new patients to the HNSCS clinics via the CG-CAHPS visit survey. 3. Examining relationships between psychiatric comorbidity and patient satisfaction. 4. Examining relationships between psychiatric comorbidity and healthcare system use.

NCT ID: NCT02811549 Completed - Hearing Loss Clinical Trials

Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss

Start date: November 7, 2016
Phase: N/A
Study type: Interventional

The purpose of this feasibility study is to evaluate the benefit of unilateral implantation in adults who have severe to profound sensorineural hearing loss in one ear, and up to moderate sensorineural hearing loss in the other ear (asymmetric hearing loss).